By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SanBio, Inc. 

231 South Whisman Road, Suite A

Mountain View  California  94041-1522  U.S.A.
Phone: 650-625-8965 Fax: 650-625-8969


Company News
SanBio, Inc. And Sunovion Pharmaceuticals Inc. Begin Patient Recruitment For Phase 2b Trial To Test Regenerative Treatment For Chronic Stroke In North America 12/21/2015 11:13:20 AM
SanBio, Inc. Begins Recruiting Patients To Test Regenerative Treatment For Traumatic Brain Injury 10/5/2015 10:47:53 AM
SanBio, Inc. Announces Publication In Stem Cells And Development 5/20/2015 10:22:23 AM
SanBio, Inc. Granted Key Patent In New Treatment For Chronic Stroke 5/15/2015 10:56:35 AM
SanBio, Inc. Scientist To Present On Stroke And Stroke Therapies At The Women’s Intelligence Trust 2015 Forum 4/30/2015 12:42:47 PM
SanBio, Inc. Announces Pricing Of Initial Public Offering On Tokyo Stock Exchange 4/8/2015 11:00:26 AM
SanBio, Inc. Announces The First Public Presentation Of Data From Its On-Going Human Clinical Trial Of Cell Therapy For Chronic Stroke Disability 2/14/2014 9:44:58 AM
SanBio, Inc. Announces the Completion of Enrollment of Its Clinical Trial of Cell Therapy for Chronic Stroke Deficits 9/4/2013 10:09:56 AM
SanBio, Inc. Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product, SB623, in Patients With Traumatic Brain Injury 6/11/2013 8:26:34 AM
SanBio, Inc. Announces Enrollment of the Second Cohort of Patients in Its Clinical Trial of Stem Cell Therapy for Chronic Stroke 1/14/2013 9:57:30 AM